Trademark: 97773407
Word
AVENCELL
Status Date
Tuesday, July 16, 2024
Filing Date
Monday, January 30, 2023
Published for Opposition
Tuesday, May 21, 2024
5 Pharmaceutical and biological preparations for the treatment of cancer and autoimmune diseases; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics for the treatment of cancer and autoimmune diseases; pharmaceutical preparations, namely, T-cell based therapeutics to treat cancer and autoimmune disease
42 Pharmaceutical research and development; scientific research, development, and analytical services in the field of pharmaceuticals, biopharmaceuticals, gene, genome, and cellular editing, modulation, and modification, and T-cell based therapeutics
Feb 2, 2023
New Application Entered
Feb 16, 2023
New Application Office Supplied Data Entered
Oct 26, 2023
Assigned To Examiner
Oct 26, 2023
Non-Final Action Written
Oct 26, 2023
Non-Final Action E-Mailed
Oct 26, 2023
Notification Of Non-Final Action E-Mailed
Jan 12, 2024
Application Extension To Response Period - Received
Apr 5, 2024
Teas/Email Correspondence Entered
Apr 5, 2024
Correspondence Received In Law Office
Apr 5, 2024
Teas Response To Office Action Received
Apr 17, 2024
Approved For Pub - Principal Register
Jan 12, 2024
Application Extension Granted/Receipt Provided
May 1, 2024
Notification Of Notice Of Publication E-Mailed
May 21, 2024
Published For Opposition
May 21, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 16, 2024
Noa E-Mailed - Sou Required From Applicant
Trademark Alertz updated from USPTO on 2030-01-24
